Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Generation of cytotoxic free radicals refers to the biochemical formation of highly reactive molecules (including reactive oxygen and nitrogen species) that contain unpaired electrons. These species are produced endogenously during normal metabolism (especially mitochondrial respiration, immune responses, and enzymatic reactions) or exogenously via environmental exposures (radiation, pollutants, drugs). Free radicals can initiate chain reactions that result in damage to DNA, proteins, and lipids, leading to cell death and dysfunction. While cytotoxic free radical generation is critical for immune defense mechanisms and some anticancer strategies (such as certain chemotherapies), excessive or misregulated production contributes to diverse pathologies including cancer, inflammation, neurodegeneration, and cardiovascular disease. Therapeutic modulation focuses on antioxidants or agents that selectively generate or neutralize free radicals. It is important to note that "generation of cytotoxic free radicals" is not a discrete molecular entity, but an overarching process central to multiple disease mechanisms and drug actions, and should not be classified as a canonical drug target.
Drugs may inhibit, scavenge, or neutralize free radicals (antioxidant action); Some anticancer drugs generate cytotoxic free radicals to damage tumor cell DNA/proteins; Activation of signaling pathways leading to apoptosis or necrosis via oxidative damage
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Generation of cytotoxic free radicals.